Skip to main content

Table 1 Metabolites identified across 3- or 7-day-induced anoikis-resistant and wild-type NCI-H460 cells

From: How do prolonged anchorage-free lifetimes strengthen non-small-cell lung cancer cells to evade anoikis? – A link with altered cellular metabolomics

Retention time (min)

Metabolites

Identification

p-value

4.013

O-Ethylhydroxylamine

MS, RI

ns

4.853

Octane

MS, RI

ns

7.564

1-(3-Methylbutyl)-2,3,4,6-tetramethylbenzene

MS, RI

< 0.05

7.958

Hydroxylamine

MS, RI

ns

8.614

1-Piperidinecarboxaldehyde

MS, RI

ns

8.629

1-Ethylpyrrolidine

MS, RI

< 0.05

8.864

Oxalic acid

MS, RI

< 0.001

8.984

Isopropyl propionate

MS, RI

ns

9.093

 N-methylmetadrenaline

MS, RI

ns

10.582

Dodecane

MS, RI

ns

11.982

Tyramine

MS, RI

ns

12.005

Ethanolamine

MS, RI

ns

12.424

Diethylene glycol

MS, RI

ns

12.429

Benzene, 1,3-bis(1,1-dimethylethyl)-

MS, RI

ns

12.548

Carbamic acid

MS, RI

ns

13.602

Phosphate

MS, RI

ns

13.723

Glycerol

MS, RI

ns

13.915

Phosphonic acid derivative

MS, RI

ns

13.967

Tridecane

MS, RI

ns

14.553

Glycine

MS, RI

ns

14.770

1-Decanol

MS, RI

ns

15.055

Cyclohexasiloxane, dodecamethyl-

MS, RI

ns

18.509

β-Alanine

MS, RI

< 0.05

20.734

Malic acid

MS, RI

ns

23.042

Ethyne, fluoro-

MS, RI

ns

23.242

Diethyl Phthalate

MS, RI

ns

24.512

 L-Glutamic acid

MS, RI

ns

26.024

Pyrophosphate

MS, RI

ns

27.506

Putrescine

MS, RI

< 0.05

29.024

Phosphorylethanolamine

MS, RI

ns

30.152

Myristic acid

MS, RI

ns

30.922

Phenylephrine

MS, RI

ns

31.771

Alanylglycine

MS, RI

ns

32.375

Glucose

MS, RI

ns

36.736

Myo-Inositol

MS, RI

ns

39.287

Stearic acid

MS, RI

ns

55.701

Cholesterol

MS, RI

< 0.001

  1. The significance (p)-value among different cell types for each metabolite was determined by analysis of variance, where ns = not significant (p > 0.05); MS = mass spectra, RI = retention index